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1 |  INTRODUCTION
Medulloblastoma is a diverse group of cerebellar tumors 
initiated from poorly differentiated neuroectodermal stem 
cells and characterized by the involvement of the genetic 
and epigenetic alterations in tumor development and treat-
ment response (Aguilera et al., 2009; Hooper, Hawes, 
Kees, Gottardo, & Dallas, 2014). Four medulloblastoma 
subgroups that vary in their clinical outcome, age, gender, 
and molecular signatures have been identified (Hovestadt 
et al., 2019). These include; the WNT subgroup, compris-
ing 10% of cases and characterized by the activation of the 
wingless-type signalling pathway (Jones et al., 2012); the 
sonic hedgehog (SHH) subgroup, which represents 20% of 
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Abstract
Background: Repressor element 1-silencing transcription factor (REST) acts as a 
transcriptional repressor by recruiting several chromatin modifiers, including histone 
deacetylase (HDAC). Elevated REST expression in medulloblastoma has been as-
sociated with tumor progression nevertheless, the tumor shows high sensitivity to 
HDAC inhibitors (HDACi). However, the functional implications of REST and its 
requirement for HDACi-induced anti-cancer effects are not well understood.
Methods: In this study, the expression of REST was evaluated across the medullo-
blastoma subgroups and subtypes using published gene expression data. Further, the 
expression of REST was modulated using the CRISPR/Cas9 knockout and shRNA 
knockdown in the Daoy medulloblastoma cell line.
Results: The results of this study showed that the expression of REST is elevated 
in most medulloblastoma subgroups compared to the non-cancerous cerebel-
lum. Blocking of REST expression resulted in increasing the expression of REST-
regulated genes, a moderate decrease in the fraction of the cells in the S-phase, and 
reducing the cells' migration ability. However, REST deficiency did not lead to a 
marked decrease in the Daoy cell viability and sensitivity to HDACi.
Conclusion: The findings of this study indicate that REST is not essential for sus-
taining the proliferation/viability of the Daoy cells. It also revealed that the anti-
proliferative effect of HDACi is independent of REST expression.
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medulloblastomas and displays an activated SHH signalling 
pathway (Pugh et al., 2012); ‘Group 3’ which represents 
around 19% of cases and occurs exclusively in children, 
and ‘Group 4’ which makes up to 40% of cases and often 
exhibits isochromosome 17 amplification (Hovestadt et al., 
2019). Recently, gene expression and DNA-methylation 
profiling of medulloblastoma tumors revealed a significant 
heterogeneity within these subgroups, which resulted in 
further stratification of the medulloblastoma tumors into 
12 different subtypes (known as WNTα and β, SHHα, 
β, γ and δ, Group 3α, β and γ, and Group 4α, β and γ) 
(Hovestadt et al., 2019). These subtypes are characterized 
by the activation of different molecular pathways and dis-
play different clinical outcomes ranging from favorable to 
poor prognosis (Cavalli et al., 2017).
Approximately 80% of medulloblastoma tissue samples 
have been reported to display an elevated repressor element 
1-silencing transcription factor (REST) expression which is 
concomitant with poor cellular differentiation (Fuller et al., 
2005). Medulloblastoma cases with elevated REST expres-
sion are often associated with a more dismal prognosis, fre-
quent occurrence of metastasis, and poor overall survival 
compared to ‘REST-low’ and ‘REST-negative’ tumors (Su, 
Kameoka, Lentz, & Majumder, 2004; Taylor et al., 2012; 
Wu et al., 2012). Accordingly, REST has been suggested 
to play a central role in sustaining the tumorigenic poten-
tial of medulloblastoma cells due to its ability to block 
the differentiation of neuronal stem cells which promotes 
the self-renewal capacity of tumor cells (Jørgensen et al., 
2009; Majumader, 2006; Negrini, Prada, D’Alessandro, & 
Meldolesi, 2013). REST is a DNA binding protein with 
nine zinc-fingers (eight in the DNA binding part and one 
in the carboxy-terminal domain [C-terminal]). The tran-
scriptional repression of REST is induced when it binds 
to a highly conserved DNA sequence known as repressor 
element 1 (RE1), which presents in the promoter region of 
a large number of genes. When REST binds to an RE1 site 
both its N-terminal and C-terminal domains work as hubs 
to recruit various chromatin remodeling and histone-modi-
fying enzymes. These include SIN3 transcription regulator 
family member A (SIN3A), REST corepressor 1 (RCOR1), 
SWI/SNF-related, matrix-associated actin-dependent reg-
ulator of chromatin subfamily a member 4 (SMARCA4), 
HDAC1, HDAC2, HDAC4, HDAC5, lysine demethy-
lase 1A (KDM1A), and synaptonemal complex protein 1 
(SYCP1) (Barrios et al., 2014; Ooi & Wood, 2008).
Histone deacetylases (HDACs) are a group of epigenetic 
molecular switches that induce their function by binding to 
several repression complexes including REST. Upon binding 
to REST, they remove the acetyl group from acetylated lysine 
amino acid on histone tails which lead to an increase in the 
electrostatic binding between the histone tails and surrounding 
DNA, which in turn blocks the access of the transcriptional 
machinery (Chueh, Tse, Tӧgel, & Mariadason, 2015).
In clinical trials, several HDAC inhibitors (HDACi) have 
shown promising anti-cancer activity in treating several he-
matological malignancies and solid tumors (Eckschlager, 
Plch, Stiborova, & Hrabeta, 2017). HDACi are a family of 
anti-cancer drugs that change the acetylation status of histone 
and non-histone proteins causing changes in gene expression, 
cell metabolic activity, and cell cycle which eventually result 
in tumor cell death (Häcker et al., 2011). Interestingly, trans-
formed cells are more sensitive to HDACi than normal cells 
(Eckschlager et al., 2017; Li & Zhu, 2014). However, some 
tumors exhibit limited sensitivity to HDACi, which could be 
due to the upregulation of genes that promote tumor growth 
such as nuclear factor kappa B (NF-kB) and anti-apoptotic 
protein such as myeloid Cell Leukemia Sequence 1 (Mcl-1) 
(Ma, Ezzeldin, & Diasio, 2009).
In this study, we sought to investigate the function of 
REST in the Daoy medulloblastoma cell line in order to 
determine whether REST repression is required for HDACi 
anti-cancer effects. The Daoy cell line is a widely used me-
dulloblastoma cell line that was established from a posterior 
fossa tumor classified as the SHH subgroup and the elevated 
REST expression in this cell line has been reported in sev-
eral studies (Fuller et al., 2005; Ivanov, Coyle, Walker, & 
Grabowska, 2016; Lawinger et al., 2000; Othman et al., 2014; 
Taylor et al., 2012). To examine REST deficiency, we used a 
CRISPR/Cas9-based knockout and a small hairpin (sh)RNA 
knockdown approach. Our results showed that REST expres-
sion was neither critically required for Daoy proliferation, nor 
for HDACi-induced anti-proliferation effects, hence suggest-
ing that the HDACi-anticancer mechanism is independent of 
REST expression in the Daoy cells.
2 |  MATERIALS AND METHODS
2.1 | Ethical compliance
All procedures performed in this study were in accordance 
with the ethical standards of the University of Leeds.
2.2 | Cell culture
The human medulloblastoma Daoy cell (ATCC HTB-186) was 
cultured in Dulbecco's Modified Eagle's Medium (DMEM, 
Life Technologies) supplemented with 10% (v/v) Fetal Bovine 
Serum (FBS, Gibco), and 1% penicillin and streptomycin 
(Sigma). The cells were cultured at 37°C incubator in 5% CO2 
and harvested using trypsin-EDTA (Sigma). All experiments 
were conducted on cells with fewer than 15 passages.
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2.3 | HDAC inhibitors
SAHA (10009929), MS-275 (13284), MI192 (18288), and 
Apicidin (10575) were purchased from Cayman Chemical 
and dissolved in DMSO (Dimethyl sulfoxide, Sigma). 
Valproic acid (VPA) was purchased from Sigma (P4543) and 
prepared in water. The cells were treated with SAHA (5 µM), 
MS-275 (5 µM), MI192 (3 µM), Apicidin (3 µM), and VPA 
(10 mM).
2.4 | REST knockout via CRISPR/Cas9
A CRISPR/Cas9 guide RNA system (OriGene, KN314675) 
was used to target two different DNA sequences in exon 2 of the 
REST gene (NG_029447.1). Two guide sequences (gRNA1: 
5′-CGCACCTCAGCTTATTATG C-3′ and gRNA2: 5′-TG 
GCAAATGTGGCCTTAACT-3′) were cloned into the 
pCas-Guide vector (which includes a Cas9 expression cas-
sette) by OriGene. The constructs pCas-Guide1 (OriGene, 
KN211570G1), pCas-Guide2 (OriGene, KN211570G2), and 
the pCas-Scramble negative control (OriGene, GE100003) 
were sequenced to confirm the correct insertion sequence. 
The transfection reactions were performed in 6-well plates 
(Nunc) seeded with 3.5  ×  104 Daoy cells and cultured in 
DMEM supplemented with 10% FBS. After 24 h (50–70% 
confluence), the cells were transfected with one part of pCas-
Guide1 plasmids (2  µg) suspended in Opti-MEM (Gibco) 
and three parts (6 µl) of Lipofectamine 2000 transfection 
reagent (Invitrogen). After 4 h, the transfection media was 
replaced with 2 ml of complete DMEM and the cultures were 
re-incubated for 48 h. The cells were then plated in a 96-
well plate at a cell dilution of 1 cell/100 µl in order to es-
tablish monoclonal cell clones. The monoclonal expansion 
was evaluated microscopically and screening for the genome 
editing was performed (cells passage 5) by PCR-amplifying 
the CRISPR/Cas9 editing site. The products were then se-
quenced using the DNA Sanger sequencing and the results 
were compared to the reference human genome. The cells 
that showed genome editing were propagated for further 
analysis and the efficiency of REST knockout was verified 
by Western blot analysis using anti-REST antibody (1:1000, 
OriGene, TA330562).
2.5 | Knockdown REST expression 
using shRNA
Two shRNA sequences were designed (shRNA1: 5′-AGCT 
AAAAACAGTGTAATCTACAGTAT CACTTCTCTTGA 
AAGTGGATACTGTAGATTACACT-3′ and shRNA2: 5′-GC 
TAAAAAAGCAGA ATCTGAAGAACAGTTTCTCTTGA 
AAACTGTTCTTCAGATTCTGCT-3′) and cloned into 
pSUPER-Puro plasmid (Addgene). The constructs were se-
quenced to confirm their correct insertion and the transfec-
tion was performed using Lipofectamine 2000 with 750 ng 
of the plasmid. After 48 h, the transfected cells were treated 
with puromycin (Sigma) at a concentration of 5 µg/ml until 
all the non-transfected cells had been killed (10 days). The vi-
able cells from the shRNA1 and two transfections were then 
plated in 96-well plates (Nunc) at a cell count of 1 cell/100 µl 
in order to generate monoclonal cell clones. The monoclonal 
growth was evaluated microscopically and the screening for 
the pSUPER genome integration was performed using poly-
merase chain reactions (PCR). The monoclonal cells with 
low REST expression were expanded and propagated for fur-
ther analysis.
2.6 | Cell proliferation and sensitivity 
to HDACi
The cells were seeded in 96-well plates at a cell density of 
3.5 × 104 cells/ml and cultured at 37°C in 5% CO2. The sen-
sitivity to HDACi was measured by replacing the culture 
media with complete media containing the required con-
centration of the inhibitors. The growth and sensitivity to 
the HDACi were assayed after 24, 48, and 72 h using MTT 
(3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 
Bromide) assay. The MTT analyses were performed by re-
placing the culture media with 50 µl of 0.5 mg/ml of MTT 
reagent (Sigma) prepared in complete culture media and 
the reaction was incubated at 37°C. After 90 min, the MTT 
solution was replaced with acidified isopropanol (0.04 M 
HCL) (Sigma), and the MTT absorbance was measured 
at 590 nm with a reference filter of 720 nm using a spec-
trophotometer plate reader (FLUOstar Omega, BMG 
Labtech).
2.7 | Wound healing assay
The cells were cultured in 6-well plates (Nunc) using com-
plete DMEM culture media at a cell density of 1 × 105 cell/
ml and incubated at 37°C in 5% CO2. After 24 h the growth 
was examined under an inverted microscope and the cell 
monolayer (at 90–100% confluence) was scratched by pass-
ing a sterile 200 μl pipette tip across the middle of the well in 
vertical and horizontal directions. The well was then gently 
washed twice with phosphate-buffered saline (PBS, Oxoid), 
fed with serum-free media, and imaged at the intersection be-
tween the vertical and horizontal scratches. A second image 
was taken 24 h after ‘wounding’ and the cell wound closure 
was analyzed using the TScratch software (CSElab, Zurich, 
Switzerland) (Gebäck, Schulz, Koumoutsakos, & Detmar, 
2009).
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2.8 | Cell cycle analysis
The cell cycle analysis was performed by harvesting the cells 
at 80–90% confluence (single-point analysis) and at 24, 48, 
and 72 h (time courses analysis). The cells were then sus-
pended in 70% ethanol and stored at −20°C for at least 24 
h. Subsequently, the cells were treated with Ribonuclease 
A (Sigma), stained with Propidium iodide (PI, Sigma), and 
analyzed on BD LSR II Fortessa flow cytometer using 562–
588 nm band pass filter. The percentages of the cells were 
estimated by deconvoluting the histograms using ModFit LT 
DNA analysis software (Verity Software House version 3.2).
2.9 | Western blot analysis
The cells were harvested, resuspended in PBS, 0.5% Triton 
X 100 (v/v) (Sigma), 0.02% (w/v) sodium azide (Sigma), and 
2  mM phenylmethylsulfonyl fluoride (PMSF, Cell Signal) 
and incubated for 10 min on ice. The nuclei were then pel-
leted by centrifugation at 4°C and resuspended in 20  mM 
HEPES-KOH (Sigma), 420  mM NaCl (Sigma), 25% (v/v) 
glycerol (Sigma), 1.5 mM MgCl2 (Sigma), 0.2 mM EDTA 
(Sigma), 0.5 mM dithiothreitol (Sigma), 0.2 mM PMSF, sup-
plemented with protease inhibitor cocktail (Sigma) for 20 
min on ice. The lysate was centrifuged at 4°C and the super-
natant was used in all Western blot analyses.
Western blot was performed on 8% SDS-polyacrylamide 
(Bio-Rad) resolving gels using 80 µg of protein per lane and the 
separated protein was transferred to a hydrated HYBOND–P 
PVDF membrane (Amersham). Immunoblotting with pri-
mary antibody was carried out at 4°C overnight using a 
1:1000 dilution of rabbit anti-REST (OriGene, TA330562) 
and a 1:10000 dilution of mouse anti-β-actin (Sigma, A1978) 
antibodies. The detection with secondary HRP-conjugated 
antibodies was performed using a dilution of 1:20000 an-
ti-rabbit (Cell Signalling) and 1:40000 dilution of anti-mouse 
(Cell Signalling) antibodies for 1 h at room temperature. 
Immunoreactive bands were visualized by ECL kit (Enhanced 
Chemiluminescence, GE Healthcare) and scanned using the 
LAS-3000 intelligent dark box (Fujifilm).
2.10 | Quantitative SYBR green real-time 
PCR (qRT-PCR)
The total RNA was isolated using TRI-reagent (Sigma-
Aldrich) and reverse-transcribed using Promega cDNA syn-
thesis reagents. The qRT-PCR reactions were prepared using 
2X SensiMix SYBR & Fluorescein kit (Bioline) with 0.6 µM 
of forward (FWD) and reverse (REV) primers (REST [FWD: 
5′-ACTTTGTCCTTACTCAAGTTCTCAG-3′, REV: 5′-AT 
GGCGGGTTACTTCATGTT-3′], RNU6 [FWD: 5′-CTCGC 
TTCGGCAGCACA-3′, REV: 5′-AACGCTTCACGAATTT 
GCGT-3′], SNAP25 [FWD: 5′-CGTCGTATGCTGCAACT 
GGTTG-3′, REV: 5′-GGTTCATGCCTTCTTCGACACG-3′], 
SYN1 [FWD: 5′-AGATTTTTGGGGGACTGGAC-3′, REV: 
5′-TGTCTTCATCCTGGTGGTCA-3′], STMN2 [FWD: 5′-TG 
AAGTCGTTTCTCCCCAAC- 3′, REV: 5′-TCACAGCTTGC 
TCACAATGA-3′], GRIA2 [FWD: 5′-TTGACTTCTCAAAG 
CCCTTCA-3′, REV: 5′-GGCTAAAGGATCAAGAAAGGA 
A-3′], REST Bi-allelic genome editing [FWD: 5′-GCAACAT 
TGGAATGGCCCTG-3′, REV: 5′-ATGGCGGGTTACTTCA 
TGTT-3′]). The amplification was performed on Rotor-Gene 
6000 (Corbett series) using the following PCR conditions: 95°C 
for 10 minutes, 40 cycles of; 95°C for 10 s, 60°C for 15 s, and 
72°C for 20 s. The reaction was then followed by a melting tem-
perature step ramping from 72°C to 95°C. The qRT-PCR data 
were analyzed using Rotor-Gene 6000 Series Software (Qiagen) 
and the relative gene expression was normalized to the expres-
sion of U6 Small Nuclear 1 (RNU6, also known as RNU6-1) 
housekeeping gene due to its consistent high expression in 
transformed cells compared to healthy controls and it is also 
characterized by its narrow standard deviation (Ma et al., 2018; 
Manterola et al., 2014; Rice, Roberts, Rai, & Galandiuk, 2015).
2.11 | Analysis of GEO-NCBI gene 
expression data sets
To evaluate the expression of REST, SYN1, SNAP25, STMN2, 
and GRIA2 in human medulloblastoma and normal cerebellum, 
we used the Gene Expression Omnibus (GEO, NCBI) data sets; 
GSE85217 (Cavalli et al., 2017), GSE10 9403 (Rivero-Hinojosa 
et al., 2018), GSE13162 (Chen-Plotkin et al., 2008), GSE42658 
(Henriquez et al., 2013), GSE68776 (Svoboda et al., 2014), and 
GSE86574 (Amani et al., 2017) (was used for normal human 
cerebellum), and GSE34101 (Ngo et al., 2014), GSE20492 
(Vogel et al., 2010), GSE77947 (Gonçalves da Silva et al., 
2017) (was used for the Daoy cell gene expression) (Barrett 
et al., 2012). The data were analyzed using ExAtlas software 
(https://lgsun.irp.nia.nih.gov/exatl as/) (Sharov, Schlessinger, 
& Ko, 2015). The analysis was performed by transforming the 
values into log2 and the correlation between the data of the 
selected samples was performed by normalizing the values as 
described previously (Sharov et al., 2015). The quality of the 
normalized samples was assessed by the standard deviation and 
ANOVA with error variance adjustment (also, known as em-
pirical error variance) (Sharov et al., 2015).
2.12 | Statistical analysis
The significant difference between the means was evalu-
ated using Student's t-test (Unpaired, two-tailed, assuming 
equal standard deviation) and One-Way ANOVA (assuming 
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Gaussian distribution) and p value of <0.05 was considered 
significant. The data were presented as means ± standard 
error of mean (SEM). Statistical analysis was performed 
using GraphPad Prism version 8.00 for Windows, GraphPad 
Software, La Jolla California USA (www.graph pad.com).
3 |  RESULTS
3.1 | REST expression is elevated in 
medulloblastoma tumors compared to normal 
cerebellum
Elevated REST expression in medulloblastoma tumors has 
been reported in several studies; however, it is unclear whether 
all medulloblastoma subgroups and subtypes display an el-
evated REST expression (Fuller et al., 2005; Su et al., 2004; 
Taylor et al., 2012). In this study, we used the GEO-NCBI 
gene profiling data of tissue samples from medulloblastoma 
patients to explore the difference in the expression of REST 
between the medulloblastoma subgroups. Moreover, we used 
the gene expression of normal cerebellum data to compare the 
difference between the subgroups and normal cerebellum. The 
analysis was carried out using the GSE85217 data set which 
contains 763 primary medulloblastoma tissue samples. They 
were classified into the four medulloblastoma (WNT, SHH, 
Group 3, and Group 4) subgroups and the 12 subtypes based on 
their genetic and methylation profiles (Hovestadt et al., 2019).
Comparison of REST expression between the medullo-
blastoma groups and normal cerebellum showed a significant 
F I G U R E  1  Comparing REST 
expression and its functional effect between 
medulloblastoma and normal cerebellum 
tissue samples. The expression results of 
REST (a and b), SNAP25 (c), SYN1 (d), 
STMN2 (e), and GRIA2 (f) were extracted 
from the GEO NCBI database and analyzed 
using the ExAtlas tool (Sharov et al., 2015). 
The samples were classified into the four 
medulloblastoma subgroups (a) and the 
twelve subtypes (b-f). (g) Compares the 
expression of REST between the Daoy cell 
and normal cerebellum. (h) Displays the 
expression of some of the RE1-containing 
genes in Daoy cells and normal cerebellum. 
The expression values are represented by 
the circular dots and the difference between 
the means was calculated either by using a 
two-tailed Student's t-test (a, b, g, and h) or 
One-Way ANOVA test (to compare more 
than 2 groups, b). Error bars depict standard 
error of mean (SEM). N.Cere, Normal 
Cerebellum
(a) (b)
(c) (d)
(e) (f)
(g) (h)
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increase in REST expression by ~1.6-fold (p  <  0.0001) 
(Figure 1a). Among the medulloblastoma subgroups, the 
WNT subgroup showed the highest expression of REST, 
whilst the mean REST expression was lowest in Group 4. 
Both of SHH and Group 3 showed approximately equivalent 
expressions with some variations between the samples of the 
SHH subgroup (Figure 1a).
We clustered the samples according to the proposed 12 
medulloblastoma subtypes in order to demonstrate the ex-
pression differences of REST between and within the sub-
types (Hovestadt et al., 2019). The analysis revealed that 
the WNT β subtype displayed the highest REST expres-
sion; however, the difference in the mean between WNT 
β and α was statistically insignificant (Figure 1b). The re-
sults revealed a statistically significant difference between 
the means of the SHH subtypes as determined by One-Way 
ANOVA (p  <  0.0001). Both α and β subtypes displayed 
a significant (p  <  0.0001) elevated REST expression by 
~0.5%-fold change compared to γ and δ subtypes. Group 3 
showed comparable expression of REST between the sub-
types (p = 0.0539). Within Group 4, there was a significant 
difference between the means of both α and β subtypes, and 
they showed the lowest expression of REST compared to the 
γ subtype (p < 0.0001) (Figure 1b).
In order to evaluate the functional effect of elevated REST 
expression, we extracted the expression values of REST-
regulated genes that are characterized by high occupancy of 
REST to their RE1 sites (Bruce et al., 2004; Calderone et al., 
2003). These included Synapsin I (SYN1), Synaptosome-
Associated Protein 25 (SNAP25), Stathmin 2 (STMN2), 
and glutamate Ionotropic Receptor AMPA Type Subunit 2 
(GRIA2) (Shimojo & Hersh, 2004). The results showed lower 
expression of SYN1 and SNAP25 in the medulloblastoma 
subtypes compared to normal cerebellum. They also showed 
a lower expression in the subtypes that displayed an elevated 
REST expression, such as the WNT subtypes, when com-
pared to the subtypes with low REST expression, in partic-
ular Group 4 (Figure 1b-f). Unexpectedly, the expression of 
STMN2 and GRIA2 was comparable in the medulloblastoma 
subtypes compared to the normal cerebellum, apart from the 
GRIA2 expression (p < 0.001) in the WNT and Group 3 sub-
types (Figure 1e,f).
Further, we studied the differential expression of REST 
between the Daoy cells and normal cerebellum. The results 
showed that the expression of REST in the Daoy cell was two-
fold greater than in normal cerebellum (p < 0.0001, Figure 1g). 
To evaluate whether the elevated REST expression had a sig-
nificant functional effect on the RE1-containing genes, we 
compared the expression of REST-regulated genes between 
the Daoy cell line and normal cerebellum. The results showed 
that the expression of these genes was around twofold lower 
(p < 0.0001) in Daoy cells compared to normal cerebellum 
(Figure 1h).
3.2 | REST deficiency resulted in the 
upregulation of RE1-containing genes
To study the effect of REST ‘loss-of-function’ on the Daoy 
cells, and to investigate whether HDACi induce their effect 
through the recruitment of HDACs into the REST repression 
complexes, we disrupted REST expression using both CRISPR/
Cas9 and shRNA approaches. For CRISPR/Cas9-mediated 
knockdown, two guide RNA (gRNA) sequences were used to 
target two different regions of exon 2 of the REST gene. For 
yielding the REST knockdown, two shRNA sequences were 
designed to target exons 2 and 4 of REST and selection for 
stable REST downregulation was carried out using puromycin 
(5 µg/ml for 10 days). The cells afforded by the CRISPR/Cas9 
and shRNA approaches were grown at clonal cell densities and 
the expression of REST was further analyzed by Western blot. 
A cell clone with a complete absence of REST expression, 
hereinafter referred to as KO, was identified (Figure 2a). As 
with most nuclear transcription factor proteins, the abundance 
of REST expression is low when compared to the highly abun-
dant β-actin nonetheless, semi-quantification of protein levels 
is clearly possible based on these blots (Figure 2b). The bial-
lelic editing of REST (exon 2) in the clonally-derived KO cells 
was further investigated using a qRT-PCR reaction with a pair 
of primers that specifically amplifies the wild-type sequence 
and does not give amplification when the target sequence is ed-
ited. The results of this analysis showed no amplification with 
the KO cells which confirm the genome editing of all REST 
alleles in this clone (Figure 2c).
For the shRNA-mediated knockdowns, the Western blot 
analysis identified an expandable cell clone with ~60% re-
duction in REST expression, hereinafter referred to as KD 
(Figure 2a,b). The qRT-PCR results of this clone showed a 
significant reduction in the REST mRNA level by more than 
50% compared to the empty vector control (Figure 2d).
In addition, we studied the functional impact of REST de-
ficiency on the expression of the SYN1, SNAP25, STMN2, 
and GRIA2 genes between the KO and KD and the control 
cells. The qRT-PCR results showed a significant increase in 
the expression of these genes by more than eightfold in the 
KO and KD cells (p ≤ 0.03), whereas the expression in the 
KO cell was almost twofold higher than the KD (Figure 2e-
h). Unexpectedly, the expression of STMN2 in the KD cell 
clone was approximately onefold higher than its expression 
in the KO cells (Figure 2g).
3.3 | REST deficiency does not strongly 
inhibit cell proliferation but affects the cell 
migration potential
Several studies that modulated REST expression by gene 
knockdown suggested the direct involvement of REST in 
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reducing cancer cell growth (Conti et al., 2012; Fuller et al., 
2005; Kamal et al., 2012; Taylor et al., 2012; Zhang et al., 
2016). We examined the effect of REST deficiency on the 
proliferation of Daoy REST KO and KD cells and on cell 
cycle using the MTT ‏assay and flow cytometry analysis, re-
spectively. The MTT results revealed only a marginal reduc-
tion in the KO and KD cells growth rate compared to REST 
expressing cells (Figure 3a,b).
The effect of REST deficiency on the cell cycle was eval-
uated by PI staining and flow cytometry analysis. The KO 
and KD Daoy cells were harvested at an 80–100% conflu-
ency (hereinafter referred to as single time-point), and at 24, 
48, and 72 h from seeding (hereinafter referred to as time-
course analysis). The results of the single time-point analysis 
showed an ~5% increase in the accumulation of both the KO 
and KD cells at the G1 phase (p < 0.0001), and a concomi-
tant reduction in the proportion of cells in S phase compared 
to the control cells (Figure 3c). Consistently, the time-course 
analysis showed an increase in the G1 phase accumulation of 
the KO cells by 5% (p = 0.03) at 24- and 48-h before the cell 
distribution becomes comparable to the control cells at the 
72-h time point (Figure 3e-f).
To assess the effect of REST downregulation on the mi-
gration ability of Daoy cells, we used the wound healing 
assay (Jonkman et al., 2014). The assay was performed by 
scratching a mono-cell layer, re-culturing the cells in a se-
rum-free medium for 24 h, and the migration ability of the 
cells was evaluated by their ability to close the scratch. Both 
F I G U R E  2  Deficiency of REST 
expression results in the upregulation of 
RE1-containing genes. (a) Western blot 
analysis of REST expression in the KO 
and KD cells using anti-REST polyclonal 
antibody. (b) The bar chart depicts the 
densitometric quantification of the signals 
obtained by Western blotting and the values 
show the relative REST band intensity 
relative to β-actin. The expression of REST 
mRNA in the KO (c) and KD cells (d). The 
expression of SNAP25 (e), SYN1 (f), STMN2 
(g), and GRIA2 (h) in the KO and KD cells. 
Data are the averages of 6 biological repeats 
normalized to the RNU6 housekeeping gene. 
The log2 expression values are represented 
by the circular dots, the p-value was 
calculated by two-tailed Student's t-test, and 
the error bars depict SEM. EmpVec is the 
shRNA empty vector control
(a) (b)
(c) (d)
(e)
(g) (h)
(f)
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the KO and KD cells were ~40% (p < 0.0001) less efficient 
in migration as compared to their control counterparts 
(Figure 4a,b).
3.4 | Disrupting REST expression does not 
reduce the sensitivity of tumor cells to HDACi
In order to examine the sensitivity of REST-deficient Daoy 
cells to HDACi, the cells were treated with a single dose 
of the compounds and cellular viability/proliferation was 
evaluated over a period of 72 h using the MTT assay. The 
concentrations of the drugs were chosen to obtain a signifi-
cant inhibition as described in the literature (Boissinot et al., 
2012; Khan et al., 2008; Lauffer et al., 2013). The analysis 
showed that the rate of cell death in the KO and KD cells 
was comparable to the one in control cells, which suggests 
a high sensitivity of the Daoy cell line to all inhibitors used 
in our study (SAHA (Spiller, Ravanpay, Hahn, & Olson, 
2006), MS-275 (Zwergel et al., 2018), M1192 (Boissinot 
et al., 2012), Apicidin (Choi et al., 2012), and Valproic acid 
(VPA) (Li et al., 2005)). The results indicate that the down-
regulation of REST expression did not significantly reduce 
the sensitivity of the cells to the inhibitors (p < 0.0001) as 
the Daoy wildtype, KO & KD cells and their control counter-
parts displayed a similar response to HDACi (Figure 5). This 
finding may suggest that REST repression complexes are not 
the primary element of the HDACi-induced anti-proliferative 
effect and that they may act through other HDAC complexes 
or through non-histone proteins, which warrants further in-
vestigation. It should be noted that this study used one dose 
of each HDACi for 72 h on the Daoy cell line. Considering 
that these HDACi are supposed to promote pleiotropic and 
different effects depending on drug dosage, treatment length, 
and tumor cell type (Ceccacci & Minucci, 2016).
4 |  DISCUSSION
REST is a transcriptional repressor that plays a significant 
role in regulating the expression of neuronal genes (Ballas, 
Grunseich, Lu, Speh, & Mandel, 2005). In several studies, 
upregulated REST expression in medulloblastomas has been 
suggested to maintain the self-renewal potential of tumor 
cells by repressing the expression of neuronal differentia-
tion genes (Conti et al., 2012; Fuller et al., 2005; Gao et al., 
F I G U R E  3  Downregulation of REST 
expression did not inhibit tumor cell growth 
and was associated with a marginal delay in 
cell cycle progression. (a and b) The effect 
of REST deficiency on Daoy REST KO and 
KD cell proliferation, respectively. Cellular 
viability was measured using the MTT assay 
at 24, 48, and 72 h. The average of three 
biological repeats is shown as (%) relative 
to the 72-h control (the highest reading). 
Charts (c) displays the effect of REST 
modulation on the Daoy cell cycle for the 
80–100% confluency range. (d) The effect 
of REST deficiency on the Daoy cell cycle 
after 24 h (d), (e) at 48 h, and (f) at 72 h 
from the time point of cell seeding. Data are 
three biological repeats and the values are 
depicted as dots, p-value was calculated by 
two-tailed Student's t-test and the error bars 
depict SEM. EmpVec is the shRNA empty 
vector control
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2011; Gonçalves da Silva et al., 2017; Taylor et al., 2012). 
The transcription repression mechanism of REST is engaged 
by recruiting several chromatin modifiers such as HDACs 
into its repression complexes. Both in vivo and in vitro stud-
ies demonstrated that treatment with HDACi reduces tumor 
cell growth; however, it remains unclear whether the high 
REST expression contributes to the sensitivity of tumor cells 
due to the domination of HDACs in its repression complexes 
(Häcker et al., 2011; Ma et al., 2009; Nesterenko, Wanningen, 
Bagci-Onder, Anderegg, & Shah, 2012). We sought to iden-
tify the contribution of REST in the medulloblastoma cell 
line (Daoy) proliferation.
In this study, we applied the in silico analysis to explore 
differences in REST expression between the medulloblastoma 
subgroups using the publicly available gene expression data-
set [GSE85217] (Cavalli et al., 2017). The analysis revealed a 
wide variation in REST expression between the medulloblas-
toma subgroups, in particular, with the SHH subgroup and 
these findings are in line with the known medulloblastoma 
heterogeneity (Hovestadt et al., 2019). The expression of the 
analyzed RE1-containing REST target genes was overall re-
duced in medulloblastoma as compared to normal cerebellum 
tissue specimens. For example, the expression of SNAP25 
and SYN1 showed a significant reduction in their expression 
compared to normal cerebellum. Yet, the expression data 
of STMN2 and GRIA2 did not show a significant difference 
when compared to normal cerebellum tissue specimens.
We established REST loss-of-function Daoy cell clones 
(using CRISPR/Cas9 knockout and shRNA knockdowns) and 
they showed a sustainable proliferative potential. Comparing 
the REST-deficient cells to the wild-type cell showed a sig-
nificant increase in the expression of some RE1-containing 
genes; however, it did not result in differentiating the tumor 
stem cell or interrupting the oncogenic regulation. Noteworthy, 
the number of REST regulated genes has been estimated to 
exceed 2000 genes (Otto et al., 2007). Despite the enormous 
effect of REST modulation though, the REST deficient cells 
maintained their proliferative potential and did not show any 
morphological changes or cell death. These findings suggest 
a non-critical role for REST in regulating tumor cell prolifera-
tion and differentiation and may point to the existence of other 
oncogenic regulations that maintain the self-renewal potential 
of tumor stem-like cells. This conclusion is further supported 
by the findings of several of microarray and next-generation 
sequencing gene expression studies that were performed using 
primary human medulloblastoma; however, the findings of 
these studies did not suggest REST as a factor in sustaining 
the tumor cell growth (Cavalli et al., 2017; Hooper et al., 
2014; Jones et al., 2012; Thompson et al., 2006). It should 
be noted that the conclusion of our study was derived from 
one experimental cell line which represents the SHH medul-
loblastoma subtype, hence it is not known whether other cell 
models would show comparable response to REST deficiency. 
Additionally, the depletion of REST expression was performed 
in vitro, which lacks important factors of the tumor microenvi-
ronment. In vivo experiments, preferably patient-derived xe-
nograft mouse models should clarify the relationship between 
REST depletion and tumorigenesis in medulloblastoma with 
the context of the microenvironment. Collectively, our results 
indicate elevated REST expression in the Daoy cells and the 
functional impact of REST deficiency on the expression of the 
RE1-containing gene.
Further, the study has found that blocking the REST ex-
pression led to a significant decrease in migration in the 
F I G U R E  4  Downregulation of REST 
expression resulted in a reduced migration 
ability of the KO and KD cells. (a) In 
vitro wound scratch assays of Daoy, KO, 
scrambled, KD, and EmpVec (shRNA 
empty vector control) cells. (b) The bars 
show the averages of twelve biological 
replicates (dots). The p-value was calculated 
by two-tailed Student's t-test, and the error 
bars depict SEM
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F I G U R E  5  Downregulation of REST 
expression did not affect the sensitivity 
of Daoy cells to HDACi. (a and b) The 
viability of the KO and KD cells treated 
with a single dose of SAHA, (c and d) MS-
275, (e and f) MI192, (g and h) Apicidin, 
and (i and j) VPA and was measured with 
the MTT assay. The measurements were 
performed at 24, 48, and 72 h from the 
treatment and the average of three biological 
repeats is shown as (%) relative to the 72-h 
control (the highest reading). The results 
are the average of three biological repeats, 
the p-value was calculated by two-tailed 
Student's t-test, and the error bars depict 
SEM. EmpVec is the shRNA empty vector 
control
(a) (b)
(c) (d)
(e) (f)
(g) (h)
(I) (J)
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KO and KD cells. This finding is further supported by a 
previous study which revealed that knocking down REST 
in glioblastoma U-87 and U-251 cell lines, using shRNA, 
resulted in inhibiting migration in glioblastoma cells yet, 
it did not stimulate cell death or reduce tumor size (Zhang 
et al., 2016).
We also found that the depletion of REST expression re-
sulted in a marginal accumulation of Daoy cells in the G1 
phase concomitant with a slight decrease in the S phase. The 
conclusion of this work aligns with some of the recent re-
search findings. For example, Das et al., (2013) used shRNA 
to knockdown REST expression in the Daoy cells to demon-
strate that the loss of REST resulted in increased accumula-
tion in G1 phase with a concomitant decrease in the S phase 
without leading to cellular apoptosis (Das et al., 2013). They 
also reported that the loss of REST expression led to a de-
crease in the expression of MYCN (a proliferative marker) 
and an increase in the expression of certain antiproliferation 
markers such as H3 histone pseudogene 23 (H3P23) and 
USP37 (Das et al., 2013). USP37 is an element of the ubiqui-
tin system and controls the cell cycle by stabilizing cyclin-de-
pendent kinase inhibitor 1B (CDKN1B) which plays a major 
part in slowing down the progression through the G1 phase 
(Das et al., 2013). However, the association of USP37 with 
REST needs further investigation.
To the best of our knowledge, this is the first study to use 
a knockout approach to study the contribution of REST in 
medulloblastoma. Several former studies used knockdown 
approaches in their analysis and they suggested REST as a 
key contributor in tumor cell growth and apoptosis and rec-
ommended REST as a promising target for medulloblastoma 
treatment (Fuller et al., 2005; Su et al., 2004, 2006; Taylor 
et al., 2012). Moreover, previous studies used a non-func-
tional form of REST (known as REST-VP16, competes with 
REST and activates RE1-containing genes) in a Daoy xeno-
graft mouse model. These studies reported that the expres-
sion of the non-functional form of REST resulted in reduced 
tumor cell growth via the induction of apoptosis in the in vivo 
intracranial medulloblastoma (Fuller et al., 2005; Lawinger 
et al., 2000).
We hypothesized that HDACi induce their effect 
through REST repression complexes which recruit several 
HDACs (Barrios et al., 2014; Ooi & Wood, 2008). Our re-
sults showed that disrupting REST activity alone did not 
affect the sensitivity of the cell to the HDACi. This may 
indicate that these inhibitors do not entirely depend on the 
REST recruited HDACs and they possibly arrest cancer 
growth through other HDACs complexes and/or non-his-
tone protein yet, it requires further investigation. A previ-
ous study has suggested REST overexpression as a marker 
for HDACi treatment; however, the findings of this present 
study do not fully support this suggestion (Taylor et al., 
2012).
Our findings suggest that the Daoy medulloblastoma cells 
exhibit comparable sensitivity to HDACi despite the varia-
tion in the HDAC-selectivity between the drugs. For exam-
ple, the HDACi MS-275 specifically inhibits HDAC1 and to a 
lesser extent HDAC2 and HDAC3 (Adhikari, Amin, Trivedi, 
Jha, & Ghosh, 2018), MI192 and Apicidin inhibit HDAC2 
and 3 (Boissinot et al., 2012), while SAHA and VPA inhibit 
class I/II and I/IIα HDACs, respectively (Micelli & Rastelli, 
2015). Comparing our results obtained via MS-275 treatment 
with other studies that examined other medulloblastoma cell 
line (D283) suggests the high sensitivity of the Daoy cells 
to MS-275 treatment as D283 showed a minor sensitivity 
to this inhibitor (Aguilera et al., 2009). It is not known why 
medulloblastoma cells exhibit different sensitivity to HDACi 
though, we may hypothesize that each medulloblastoma cell 
line has a different genetic signature that dictates its response 
to a particular inhibitor. The sensitivity result of SAHA in 
this study is in agreement with the findings of a previous 
study that examined Daoy, D283, and D341 medulloblastoma 
cell lines (Spiller et al., 2006). The ability of SAHA to induce 
cell death among different medulloblastoma cell lines could 
be due to the efficiency of SAHA to inhibit a wider range of 
HDACs which includes all Class I/II HDACs.
To conclude, the findings of this study revealed that 
the disruption of REST expression in the Daoy experimen-
tal model resulted in the de-repression of neuronal genes, 
non-significant/marginal delay in the progression of the cells 
at the G1 phase of the cell cycle, and a significant reduction 
in the cell migration ability. However, the downregulation of 
REST was not sufficient to induce a significant effect on the 
Daoy proliferation and viability.
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